POMDOCTOR Net Receivables from 2010 to 2026

POM Stock   0.24  0.01  4.35%   
POMDOCTOR LIMITED Net Receivables yearly trend continues to be very stable with very little volatility. Net Receivables is likely to drop to about 12.8 M. During the period from 2010 to 2026, POMDOCTOR LIMITED Net Receivables quarterly data regression pattern had sample variance of 2646153.9 T and median of  782,000,000. View All Fundamentals
 
Net Receivables  
First Reported
2003-03-31
Previous Quarter
11.5 M
Current Value
15 M
Quarterly Volatility
1.3 B
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check POMDOCTOR LIMITED financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among POMDOCTOR LIMITED's main balance sheet or income statement drivers, such as Depreciation And Amortization of 147 K, Interest Expense of 14.2 M or Total Revenue of 374.2 M, as well as many indicators such as Price To Sales Ratio of 13.42, Dividend Yield of 0.0 or Days Sales Outstanding of 19.31. POMDOCTOR financial statements analysis is a perfect complement when working with POMDOCTOR LIMITED Valuation or Volatility modules.
  
Build AI portfolio with POMDOCTOR Stock
Check out the analysis of POMDOCTOR LIMITED Correlation against competitors.
Evaluating POMDOCTOR LIMITED's Net Receivables across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into POMDOCTOR LIMITED American's fundamental strength.

Latest POMDOCTOR LIMITED's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of POMDOCTOR LIMITED American over the last few years. It is POMDOCTOR LIMITED's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in POMDOCTOR LIMITED's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

POMDOCTOR Net Receivables Regression Statistics

Arithmetic Mean1,095,791,263
Geometric Mean116,623,426
Coefficient Of Variation148.45
Mean Deviation1,166,921,759
Median782,000,000
Standard Deviation1,626,700,295
Sample Variance2646153.9T
Range4.6B
R-Value(0.32)
Mean Square Error2526229.5T
R-Squared0.10
Significance0.20
Slope(104,377,458)
Total Sum of Squares42338461.6T

POMDOCTOR Net Receivables History

202612.8 M
202513.5 M
202415 M
202332.4 M
202227.3 M
2021739.6 K

About POMDOCTOR LIMITED Financial Statements

POMDOCTOR LIMITED investors utilize fundamental indicators, such as Net Receivables, to predict how POMDOCTOR Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables13.5 M12.8 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether POMDOCTOR LIMITED is a strong investment it is important to analyze POMDOCTOR LIMITED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact POMDOCTOR LIMITED's future performance. For an informed investment choice regarding POMDOCTOR Stock, refer to the following important reports:
Check out the analysis of POMDOCTOR LIMITED Correlation against competitors.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Will Pharmaceutical Retailers sector continue expanding? Could POMDOCTOR diversify its offerings? Factors like these will boost the valuation of POMDOCTOR LIMITED. Anticipated expansion of POMDOCTOR directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every POMDOCTOR LIMITED data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate POMDOCTOR LIMITED using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating POMDOCTOR LIMITED's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause POMDOCTOR LIMITED's market price to deviate significantly from intrinsic value.
It's important to distinguish between POMDOCTOR LIMITED's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding POMDOCTOR LIMITED should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, POMDOCTOR LIMITED's market price signifies the transaction level at which participants voluntarily complete trades.